Business Context and Reporting Period
Company: Maiden Holdings, Ltd. (MHLD)
Filing Type: Form 8-K (Current Report)
Date: March 24, 2025
Event: Entry into a Material Definitive Agreement (Amendment No. 2 to the Combination Agreement).
Maiden Holdings, Ltd. entered into a second amendment to its Combination Agreement with Kestrel Group, LLC, dated March 24, 2025. This amendment adjusts the exchange ratio and terms for the proposed merger that will combine Maiden and Kestrel into a new entity, Bermuda NewCo, which will be rebranded as Kestrel Group.
Key Financial Metrics and Transaction Terms
This filing details the terms of the proposed transaction rather than Maiden's standalone operating results. Key financial terms established in Amendment No. 2 include:
- Exchange Ratio: Each outstanding Maiden common share will convert into 0.05 (one-twentieth) of a Bermuda NewCo common share.
- Kestrel Equityholder Consideration:
- Cash: $40,000,000 aggregate.
- Equity: 2,750,000 common shares of Bermuda NewCo.
- Contingent Consideration: Kestrel Equityholders may receive up to the lesser of:
- Shares valued at $45,000,000 (based on VWAP), subject to EBITDA milestones.
- 2,750,000 shares of Bermuda NewCo.
- Fractional Shares: Paid in cash based on the 5-day VWAP of Maiden shares multiplied by 20.
- Options and Restricted Shares: Converted at a 0.05 ratio with adjusted exercise prices.
Note: The filing text does not provide Maiden's current revenue, profit, cash flow, margins, debt, or liquidity metrics. These figures are not included in this 8-K.
Material Changes Versus Prior Period
The primary material change is the adjustment to the Combination Agreement originally entered on December 29, 2024, and amended on February 17, 2025. The March 24, 2025 amendment specifically:
- Formalized the 0.05 exchange ratio for Maiden shareholders.
- Defined the specific cash and equity split for Kestrel Equityholders ($40M cash + 2.75M shares).
- Established the mechanics for contingent consideration tied to EBITDA milestones.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Status: The transaction is subject to conditions set forth in the Combination Agreement. A registration statement on Form S-4 has been filed but has not yet been declared effective by the SEC. Shareholder approval is required via a proxy statement/prospectus.
Risks and Contingencies:
- Regulatory Approval: The transaction is contingent on SEC effectiveness of the registration statement.
- Shareholder Approval: Maiden shareholders must vote to approve the Transactions.
- Performance Milestones: A portion of the consideration to Kestrel Equityholders is contingent on achieving specific EBITDA milestones.
Unusual Items: The filing includes biographical information for Kestrel leadership (Luke Ledbetter and Terry Ledbetter) as participants in the proxy solicitation. Neither currently owns Maiden securities.
Investor Verification Checklist
- Verify the status of the Form S-4 registration statement (File No. 333-285664) and its effectiveness date.
- Review the definitive proxy statement/prospectus for detailed risk factors and voting procedures.
- Confirm the specific EBITDA milestones required to unlock the full contingent consideration for Kestrel Equityholders.
- Check for any subsequent amendments to the Combination Agreement or changes in the exchange ratio.
- Monitor the 5-day VWAP of Maiden shares leading up to the closing date to calculate fractional share payments.